title: Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
abstract: BACKGROUND
  Cigarette smoking is the number one cause of preventable death among American Indian and Alaska Natives, AI/ANs. Two out of every five AI/AN will die from tobacco-related diseases if the current smoking rates of AI/ANs (40.8%) persist. Currently, there is no proven, effective culturally-tailored smoking cessation program designed specifically for a heterogeneous population of AI.The primary aim of this group randomized clinical trial is to test the efficacy of "All Nations Breath of Life" (ANBL) program compared to a non-tailored "Current Best Practices" smoking cessation program among AI smokers.
  
  
  METHODS
  We will randomize 56 groups (8 smokers per group) to the tailored program or non-tailored program for a total sample size of 448 American Indian smokers. All participants in the proposed study will be offered pharmacotherapy, regardless of group assignment. This study is the first controlled trial to examine the efficacy of a culturally-tailored smoking cessation program for American Indians. If the intervention is successful, the potential health impact is significant because the prevalence of smoking is the highest in this population.
  
  
  BACKGROUND
  ClinicalTrials.gov: NCT01106456.
authors: Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS, USA. wchoi@kumc.edu
authors: Won S
authors: WS
authors: Choi
authors: Babalola
authors: B
authors: Faseru
authors: Laura A
authors: LA
authors: Beebe
authors: Allen K
authors: AK
authors: Greiner
authors: Hung-Wen
authors: HW
authors: Yeh
authors: Theresa I
authors: TI
authors: Shireman
authors: Myrietta
authors: M
authors: Talawyma
authors: Lance
authors: L
authors: Cully
authors: Baljit
authors: B
authors: Kaur
authors: Christine M
authors: CM
authors: Daley
references: Cancer. 2004 Dec 1;101(11):2650-9
references: 15505784
references: Med Anthropol Q. 2006 Dec;20(4):421-40
references: 17225653
references: Prev Med. 2002 Oct;35(4):334-42
references: 12453710
references: Am J Prev Med. 2001 Apr;20(3):196-201
references: 11275446
references: JAMA. 1989 Apr 14;261(14):2101-6
references: 2926945
references: Circulation. 2005 Mar 15;111(10):1250-6
references: 15769765
references: JAMA. 1999 Jan 6;281(1):72-6
references: 9892454
references: Ethn Dis. 2010 Autumn;20(4):334-8
references: 21305818
references: MMWR Recomm Rep. 1998 Oct 9;47(RR-18):v-xv, 1-16
references: 9784089
references: Health Promot Pract. 2009 Jul;10(3):386-93
references: 18323536
references: Public Health Rep. 2002 May-Jun;117(3):281-90
references: 12432139
references: Cancer Control. 2005 Nov;12 Suppl 2:70-6
references: 16327753
references: Nicotine Tob Res. 1999;1 Suppl 2:S181-7; discussion S207-10
references: 11768178
references: Ann Epidemiol. 2002 Feb;12(2):97-106
references: 11880217
references: JAMA. 1994 Jun 22-29;271(24):1940-7
references: 8201739
references: Addict Behav. 1997 Mar-Apr;22(2):207-18
references: 9113215
references: Ethn Dis. 2006 Winter;16(1):35-40
references: 16599346
references: Cancer. 1996 Oct 1;78(7 Suppl):1592-7
references: 8839577
references: MMWR Surveill Summ. 2003 Aug 1;52(7):1-13
references: 14532869
references: MMWR Morb Mortal Wkly Rep. 2003 Aug 1;52(30):704-7
references: 12894057